Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(1): 29-34. doi: 10.15171/jcvtr.2017.04
PMID: 28451085        PMCID: PMC5402024

Original Article

Two-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy

Mehrnoush Toufan 1, Leili Pourafkari 1,2, Leyla Ghahremani Nasab 1, Ali Esfahani 3, Zohreh Sanaat 3, Alireza Nikanfar 3, Nader D Nader 2 *

Cited by CrossRef: 9

1- Vasyuk Y, Nesvetov V, Yushuk E, Scherbak M. Clinical Capabilities and Limitations in the Use of Modern Technologies in Echocardiography. Kardiologiia. 2019;59(7):68 [Crossref]
2- Bishop S, Liu S. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin. Phytomedicine. 2017;36:210 [Crossref]
3- Qiu S, Zhou T, Qiu B, Zhang Y, Zhou Y, Yu H, Zhang J, Liu L, Yuan L, Yang G, Duan Y, Xing C. Risk Factors for Anthracycline-Induced Cardiotoxicity. Front Cardiovasc Med. 2021;8 [Crossref]
4- Anqi Y, Yu Z, Mingjun X, Xiaoli K, Mengmeng L, Fangfang L, Mei Z. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy. Echocardiography. 2019;36(3):495 [Crossref]
5- Andrade-Bucknor S, Rodriguez B, Ma C, Lyubarova R, Kondapalli L. Imaging in Cardio-Oncology: Role of Novel Echo Parameters in Breast Cancer and Gynecologic Malignancies. Curr Cardiol Rep. 2026;28(1) [Crossref]
6-  Figueiras-Graillet L,  García-Jiménez Y,  Rosas-Munive E,  Nuriulú-Escobar P,  Sierra-Galán L,  Vásquez-Ortiz Z,  Ruiz-Gastelum E,  Ancona-Vadillo A,  Puente-Barragán  , Parra-Machuca M. Abordaje de la enfermedad cardiovascular en mujeres con cáncer de mama. Posición de la Asociación Nacional de Cardiólogos de México (ANCAM). Cardiovasc Metab Sci. 2020;31(3):76 [Crossref]
7- Chang H, Lee C, Su P, Li S, Chen M, Chen Y, Hsu Y, Tsai W, Liu P, Chen T, Liu Y. Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy. Sci Rep. 2021;11(1) [Crossref]
8- Bhat S, Gahungu N, Thavendiranathan P, Dwivedi G. The Role of Echocardiography in Cardio-oncology Patients: Contemporary Indications and Future Directions. Curr Cardiovasc Imaging Rep. 2019;12(12) [Crossref]
9- Zito C, Manganaro R, Cusmà Piccione M, Madonna R, Monte I, Novo G, Mercurio V, Longobardo L, Cadeddu Dessalvi C, Deidda M, Pagliaro P, Spallarossa P, Costantino R, Santarpia M, Altavilla G, Carerj S, Tocchetti C. Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC). 2021;22(4):406 [Crossref]
10- Linhares B, Linhares D, Vale R, Gonçalves D. Time to adopt a new standard method for assessing cardiac function in chemotherapy-induced cardiotoxicity in breast cancer? A systematic review and meta-analysis. Current Problems in Cardiology. 2026;51(5):103289 [Crossref]
11- Bergamini C, Dolci G, Truong S, Zanolla L, Benfari G, Fiorio E, Rossi A, Ribichini F. Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature. Cardiovasc Toxicol. 2019;19(6):485 [Crossref]